Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
1.870
-0.070 (-3.61%)
At close: Apr 9, 2026, 4:00 PM EDT
1.890
+0.020 (1.07%)
After-hours: Apr 9, 2026, 7:14 PM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $20.96 million as of April 9, 2026. Its market cap has decreased by -50.17% in one year.
Market Cap
20.96M
Enterprise Value
10.92M
1-Year Change
-50.17%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has decreased from $30.33M to $20.96M, a decrease of -30.89%. That is a compound annual growth rate of -6.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 21.75M | -35.83% |
| Dec 31, 2025 | 33.89M | -1.50% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexaria Bioscience | 23.77M |
| NanoViricides | 23.75M |
| Skye Bioscience | 23.61M |
| AEON Biopharma | 22.77M |
| Quantum BioPharma | 22.45M |
| Tempest Therapeutics | 22.38M |
| Curis | 21.82M |
| Vistagen Therapeutics | 21.80M |